IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — OncoCyte Corp. (OCX) on Tuesday reported a loss of $13.5 million in its third quarter.
The Irvine, California-based company said it had a loss of 98 cents per share.
The cancer diagnostic test developer posted revenue of $115,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
